Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 14 November 2025

Fastenal (FAST) Stock on 14 November 2025: New CFO, Barclays Price Target Cut to $44, and Fresh Undervaluation Debate

Fastenal (FAST) Stock on 14 November 2025: New CFO, Barclays Price Target Cut to $44, and Fresh Undervaluation Debate

Fastenal Company (NASDAQ: FAST) is under the spotlight again as investors digest a wave of fresh headlines: a new analysis arguing the stock may be potentially undervalued, a new chief financial officer stepping in, multiple analyst downgrades and price-target cuts, plus big institutional and insider buying in the background. Investing.com UK+4Yahoo Finance+4Fastenal Investor+4 With shares recently trading around the low‑$40s and about 19% below their 52‑week high, Fastenal is becoming a battleground name for dividend and quality‑growth investors heading into year‑end. MarketBeat+1 Where Fastenal’s stock stands today Fastenal shares are hovering just under $41 and have pulled back from a
14 November 2025
··
Caterpillar (CAT) Stock Today: Wells Fargo Starts at Overweight as Volume Momentum Builds — November 14, 2025

Caterpillar (CAT) Stock Today: Wells Fargo Starts at Overweight as Volume Momentum Builds — November 14, 2025

On Friday, November 14, 2025, investors in Caterpillar Inc. (NYSE: CAT) are digesting a wave of fresh analyst commentary, insider and institutional activity, and a detailed new look at the company’s improving volume trends — all against the backdrop of a bruising week for global equities. Caterpillar shares closed Thursday at about $553.55, down roughly 3.4% on the day as part of a broad market selloff that saw the Dow Jones Industrial Average shed nearly 800 points.StockAnalysis+1 A pre‑market update from MarketWatch early Friday showed CAT essentially flat around $553–554, suggesting investors are pausing to reassess after the sharp pullback.MarketWatch
14 November 2025
····
Bloom Energy (BE) Stock Tumbles After 343% Rally: AI Power, Leveraged ETF and Big-Money Moves on November 14, 2025

Bloom Energy (BE) Stock Tumbles After 343% Rally: AI Power, Leveraged ETF and Big-Money Moves on November 14, 2025

Bloom Energy Corporation (NYSE: BE), one of 2025’s hottest AI-and-clean-energy stories, is back in the spotlight today after a violent mid‑week sell‑off, the launch of a new 2x leveraged ETF, and fresh institutional trading disclosures. The stock remains up massively for the year – but the mood around BE has shifted from euphoria to uneasy volatility. Bloom Energy stock today: from moonshot to whipsaw According to new analysis published this morning, Bloom Energy shares are still up about 343% year‑to‑date and nearly 680% over the past 12 months, even after a steep pullback of more than 24% in the last
14 November 2025
····
Expion360 (XPON) Soars After Q3 2025 Earnings Beat: Revenue Up 72% as New CEO Takes the Helm

Expion360 (XPON) Soars After Q3 2025 Earnings Beat: Revenue Up 72% as New CEO Takes the Helm

Expion360 (NASDAQ: XPON) stock jumped more than 28% after hours as the lithium-ion battery maker posted a surprise Q3 2025 profit, crushed earnings estimates, and highlighted its new leadership team Quick Takeaways XPON Stock: Big After-Hours Pop, Still Deep in the Red Year-Over-Year Expion360 Inc. (NASDAQ: XPON), a maker of premium lithium iron phosphate (LiFePO₄) batteries for RV, marine and home energy storage, saw its stock jump 28.35% in after-hours trading on November 14, climbing to $1.63 after closing Thursday’s regular session at $1.27. Benzinga As of early afternoon trading on November 14, 2025, XPON is hovering around $1.27, giving
14 November 2025
·····
Ron Baron Says He’ll Never Sell His Tesla or SpaceX Stock: What His Bold Bet on Elon Musk Means for Investors Today

Ron Baron Says He’ll Never Sell His Tesla or SpaceX Stock: What His Bold Bet on Elon Musk Means for Investors Today

Billionaire investor Ron Baron is once again staking his reputation — and a huge chunk of his fortune — on Elon Musk. In a fresh appearance on CNBC’s Squawk Box this morning, Baron said he does not expect to sell his personal Tesla (TSLA) or SpaceX shares during his lifetime, underscoring just how long-term his conviction really is. The interview, which is being widely syndicated through outlets including MSN and YouTube, also touched on the broader stock market, Musk’s record-breaking $1 trillion Tesla pay package, and what investors can expect from today’s 32nd Annual Baron Investment Conference in New York.
14 November 2025
····
Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health, Inc. (NYSE: HIMS) is in the spotlight today after officially rolling out its new “Labs” diagnostic platform in partnership with Quest Diagnostics, even as the stock trades sharply lower and Wall Street sentiment turns more cautious. The telehealth company is trying to push deeper into preventive, data-led healthcare at the same time investors are digesting rich valuations, insider selling and tighter 2025 guidance. Investing.com+4Hims Investors+4Investing.com Australia+4 HIMS stock today: price, move and context As of early afternoon on Friday, November 14, 2025, Hims & Hers shares are: Trading has been volatile around HIMS in recent sessions,
14 November 2025
···
Anavex Life Sciences (AVXL) Stock Plunges After EMA Issues Negative Trend Vote on Alzheimer’s Drug

Anavex Life Sciences (AVXL) Stock Plunges After EMA Issues Negative Trend Vote on Alzheimer’s Drug

Anavex Life Sciences (NASDAQ: AVXL) tumbled on November 14, 2025 after Europe’s drug regulator delivered a negative trend vote on its Alzheimer’s candidate blarcamesine. The company plans a CHMP re-examination and a fresh meeting with the FDA. Here’s what happened and what comes next. By Staff Reporter — November 14, 2025 NEW YORK — Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) were under heavy pressure on Friday after the European Medicines Agency’s human medicines committee signaled it is leaning against approving the company’s experimental Alzheimer’s pill blarcamesine for early Alzheimer’s disease. Investing News Network (INN)+1 The Committee for Medicinal
14 November 2025
···
IREN Limited (IREN) Stock Plunges 12% as AI ‘Neocloud’ Trade Stumbles – Despite $9.7B Microsoft Deal (14 November 2025)

IREN Limited (IREN) Stock Plunges 12% as AI ‘Neocloud’ Trade Stumbles – Despite $9.7B Microsoft Deal (14 November 2025)

IREN Limited (NASDAQ: IREN) – the Australian-born Bitcoin miner turned renewable-powered AI data‑center operator – is having another wild session on Friday, 14 November 2025. Despite landing a landmark US$9.7 billion AI cloud contract with Microsoft earlier this month and reporting record quarterly results last week, the stock is down sharply again today as investors reassess the risks behind its breakneck expansion. IREN stock today: sharp selloff after a parabolic year As of Friday afternoon, IREN shares are trading around $48.65, down approximately 12.7% over the last 24 hours. That move caps a bruising week in which the stock has
14 November 2025
····
Virgin Galactic (SPCE) Narrows Q3 Loss, Reaffirms 2026 Space Tourism Launch as Stock Trades Near Lows

Virgin Galactic (SPCE) Narrows Q3 Loss, Reaffirms 2026 Space Tourism Launch as Stock Trades Near Lows

Virgin Galactic Holdings, Inc. (NYSE: SPCE) is back in the headlines today after releasing its third‑quarter 2025 results last night and updating investors on progress toward its long‑promised space tourism service. The company is still burning a lot of cash and generating almost no revenue, but it narrowed its quarterly loss, shored up liquidity, and reaffirmed a late‑2026 launch timeline for private astronaut flights. Virgin Galactic+1 On the market side, SPCE is trading around $3.31, giving the company a market capitalization of roughly $190 million, near the bottom of its 52‑week range between $2.18 and $8.19. StockInvest Key takeaways for
14 November 2025
···
MDA Space Stock Plunges Over 50% on SpaceX Shock, But Q3 2025 Earnings and Wireless Power Deal Rekindle Bull Hopes

MDA Space Stock Plunges Over 50% on SpaceX Shock, But Q3 2025 Earnings and Wireless Power Deal Rekindle Bull Hopes

Canadian space-tech champion MDA Space faces a brutal rerating after EchoStar’s $1.3 billion contract cancellation and SpaceX‑linked customer buzz – just as it reports surging Q3 revenue, reaffirms guidance, and announces a futuristic wireless power partnership. MDA Space (TSX:MDA) stock has more than halved amid SpaceX-related contract turmoil and Globalstar sale rumours. On 14 November 2025, the company posted strong Q3 2025 results, reaffirmed guidance and highlighted a new wireless power partnership. Here’s what today’s news means for TSX:MDA investors. MDA Space stock halves in a month as SpaceX ripples through its customer base MDA Space Ltd. (TSX:MDA; OTC:MDALF) has
14 November 2025
······
Stock Market Today, November 14, 2025: Global Sell-Off Deepens as Fed Rate-Cut Hopes Fade and Tech Rout Batters Dow, S&P 500, Nasdaq Futures

Stock Market Today, November 14, 2025: Global Sell-Off Deepens as Fed Rate-Cut Hopes Fade and Tech Rout Batters Dow, S&P 500, Nasdaq Futures

Global stock markets tumbled on Friday, November 14, 2025, as a wave of “higher for longer” interest-rate fears and mounting anxiety over lofty AI and tech valuations triggered another broad risk-off move from Asia to Wall Street. Zawya+3Reuters+3Reuters+3 Markets had spent much of the week betting the Federal Reserve would deliver another rate cut at its December meeting. By Friday, those hopes had been slashed to little more than a coin toss, leaving stocks sharply lower, bond yields grinding around the 4% mark and safe-haven currencies such as the yen and Swiss franc in demand. Zawya+2Investing.com Canada+2 Key takeaways Fed
14 November 2025
····
Pfizer Stock Surges 15% on Trump’s Pricing Pact & $7.3B Obesity Deal – Can the Rally Last?

Pfizer Stock (PFE) Before the Bell on November 14, 2025: Metsera Deal Closes, BioNTech Stake Cut and Guidance Raised

As Wall Street heads into Friday’s session, Pfizer stock is trading slightly lower in premarket action while investors digest a trio of big developments: the completed acquisition of obesity‑drug developer Metsera, a sharp reduction in Pfizer’s stake in BioNTech, and a recent earnings report that lifted 2025 profit guidance but confirmed that COVID revenue continues to fade.Pfizer+2BioSpace+2 Benzinga’s real‑time quote shows Pfizer (NYSE: PFE) around $25.6 ahead of the U.S. market open, roughly 1% belowThursday’s close of $25.79, putting the shares on track for a mildly negative start to the day.Benzinga+1 Below is what traders and long‑term investors should know before the opening bell.
14 November 2025
····
1 … 1,694 1,695 1,696 1,697 1,698 … 1,916

Stock Market Today

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

7 February 2026
CapitaLand Investment shares rose 1.3% to S$3.12 on Friday, bucking a 0.8% drop in Singapore’s benchmark index. CapitaLand Integrated Commercial Trust reported a 16.4% jump in second-half distributable income, while CapitaLand Ascendas REIT posted a 1.4% full-year rise. CapitaLand China Trust saw full-year DPU fall to 4.82 cents amid weaker yuan and occupancy. CLI reports FY2025 results on Feb. 11.
Go toTop